Headlines sometimes promise a “weapon” against Alzheimer’s. Research on cognitive leisure activities asks a more precise question: which activities are associated with which outcomes, in which people, and under what study design?
Chess can be a stimulating pastime and an opportunity to interact. That does not make it a treatment or a demonstrated way of preventing the disease.
A cohort does not test a prescription
Wu and colleagues (2023) analyse the activities of 10,318 people in Australia, aged at least 70 and generally healthy at enrolment. Their study examines dementia incidence using models adjusted for several characteristics.
| Category studied | Adjusted HR | 95% confidence interval |
|---|---|---|
| Adult literacy activities | 0.89 | 0.85–0.93 |
| Mentally active activities | 0.91 | 0.87–0.95 |
Mentally active activities include games, cards, chess, crosswords and puzzles. The study does not allow an effect specific to chess to be isolated.
These HRs are hazard ratios in the model. They are not an absolute reduction of 11 or 9 percentage points, nor an individual probability of avoiding Alzheimer’s. The outcome measured is dementia, not exclusively that disease.
Statistical adjustment reduces some differences between participants without eliminating every possible explanation. People who remain healthier may also continue their activities more often. The study does not randomly assign participants to “play chess” and “do not play”.
Prevention and support are two different questions
A trial involving people who have already been diagnosed may measure a change in mood, functioning or a cognitive score. Even a positive result would not demonstrate prevention in healthy people.
We therefore need to examine the population, the type of game, the comparison group and the outcome measured. Findings from another game or a supervised therapeutic programme do not automatically transfer to a game of chess at a club.
Keeping the right criteria
For a leisure activity, you can choose an observable goal: enjoying a session, meeting other players or learning an endgame. A change in mood or quality of life matters to the person, but it does not measure a change in the disease.
Neither a particular number of sessions per week nor a duration of 45 or 60 minutes constitutes a validated preventive dose here. If a pilot study uses that duration, it describes its protocol; it does not prescribe the same thing for everyone.
You can adapt the pace, difficulty and format to your preferences and fatigue. An interrupted or simplified game can remain an enjoyable activity. The aim is not to turn every session into a performance test.
Health involves more than a game
The WHO notes that dementia has several causes and presents modifiable risk factors, including physical activity and cardiovascular health. Playing does not replace those aspects or appropriate medical care.
If you notice persistent memory difficulties or changes in everyday activities, seek medical advice rather than treating a puzzle score or your Elo rating as a screening test.
For expertise studies and their causal limitations, see chess and the brain. The conclusion here remains limited: cognitive leisure activities deserve study, but the cited sources do not demonstrate protection specific to chess against Alzheimer’s.
Comments